SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 12, 2000, Pages 2276-2285

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric oncology group studies from 1986-1994

(5) Maloney, K W a Shuster, J J b Murphy, S c Pullen, J d Camitta, B A a

a Midwest Children's Cancer Center (United States)

b University of Florida ^* (United States)

c NORTHWESTERN UNIVERSITY (United States)

d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE (United States)

Author keywords

B lineage ALL; Infant ALL; Outcome; Prognostic factors; T lineage ALL

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CD2 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOPLASM PROTEIN; DAUNORUBICIN; DNA; DOXORUBICIN; ESTERASE; HYDROCORTISONE; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN; MERCAPTOPURINE; METHOTREXATE; PEROXIDASE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; B CELL LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 10; CHROMOSOME 4; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFANT DISEASE; INFORMATION PROCESSING; INTENSIVE CARE; ITALY; LEUKOCYTE COUNT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STEM CELL; SURVIVAL RATE; T CELL LEUKEMIA; TREATMENT OUTCOME; TRISOMY;

EID: 0034525194 PISSN: 08876924 EISSN: None Source Type: Journal
DOI: 10.1038/sj.leu.2401965 Document Type: Article

Times cited : (88)

References (36)

1
- 0022452185
- Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment
- (1986) Med Ped Oncol , vol.14 , pp. 191-194
- Mastrangelo, R.¹ Poplack, D.² Bleyer, A.³ Riccardi, R.⁴ Sather, H.⁵ D'Angio, G.⁶

2
- 9044226139
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
- (1996) J Clin Oncol , vol.14 , pp. 18-24
- Smith, M.¹ Arthur, D.² Camitta, B.³ Carroll, A.J.⁴ Crist, W.⁵ Gaynon, P.⁶ Gelber, R.⁷ Heerema, N.⁸ Korn, E.L.⁹ Link, M.¹⁰ Murphy, S.¹¹ Pui, C.-H.¹² Pullen, J.¹³ Reaman, G.¹⁴ Sallan, S.E.¹⁵ Sather, H.¹⁶ Shuster, J.¹⁷ Simon, R.¹⁸ Trigg, M.¹⁹ Tubergen, D.²⁰ Uckun, F.²¹ Ungerleider, R.²² more..

3
- 0028037399
- Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: A pediatric oncology group study
- (1994) J Clin Oncol , vol.12 , pp. 1939-1945
- Land, V.J.¹ Shuster, J.J.² Crist, W.M.³ Ravindranath, Y.⁴ Harris, M.B.⁵ Krance, R.A.⁶ Pinkel, D.⁷ Pullen, D.J.⁸

4
- 0031904557
- Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: A pediatric oncology group study
- (1998) J Clin Oncol , vol.16 , pp. 2840-2847
- Harris, M.B.¹ Shuster, J.J.² Pullen, J.³ Borowitz, M.J.⁴ Carroll, A.J.⁵ Behm, F.G.⁶ Land, V.J.⁷

5
- 85044552980
- Treatment of children with early pre-B and pre-B acute lymphoblastic leukemia with antimetabolite-based intensification regimens: A pediatric oncology group study
- (in press)
- Leukemia
- Harris, M.B.¹ Shuster, J.J.² Pullen, J.³ Borowitz, M.J.⁴ Carroll, A.J.⁵ Behm, F.G.⁶ Camitta, B.A.⁷ Land, V.J.⁸

6
- 0344333442
- Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute pediatric oncology group phase III trial
- (1998) J Clin Oncol , vol.16 , pp. 246-254
- Mahoney, D.H.¹ Shuster, J.² Nitschke, R.³ Lauer, S.J.⁴ Winick, N.⁵ Steuber, C.P.⁶ Camitta, B.M.⁷

7
- 0342445410
- Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A pediatric oncology group study
- (2000) J Clin Oncol , vol.18 , pp. 1285-1294
- Mahoney, D.H.¹ Shuster, J.J.² Nitschke, R.³ Lauer, S.⁴ Steuber, C.P.⁵ Camitta, B.M.⁶

8
- 0026769756
- Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A pediatric oncology group study
- (1992) Blood , vol.79 , pp. 3316-3324
- Harris, M.B.¹ Shuster, J.J.² Carroll, A.³ Look, A.T.⁴ Borowitz, M.J.⁵ Crist, W.M.⁶ Nitschke, R.⁷ Pullen, J.⁸ Steuber, C.P.⁹ Land, V.J.¹⁰

9
- 0032973925
- Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A pediatric oncology group study
- (1999) Leukemia , vol.13 , pp. 335-342
- Amylon, M.D.¹ Shuster, J.² Pullen, J.³ Berard, C.⁴ Link, M.P.⁵ Wharam, M.⁶ Katz, J.⁷ Yu, A.⁸ Laver, J.⁹ Ravindranath, Y.¹⁰ Kurtzberg, J.¹¹ Desai, S.¹² Camitta, B.M.¹³ Murphy, S.B.¹⁴

10
- 0031003109
- Therapeutic trail for infant acute lymphoblastic leukemia: The pediatric oncology group experience (POG 8493)
- (1997) J Ped Hematol/Oncol , vol.19 , pp. 35-42
- Frankel, L.S.¹ Ochs, J.² Shuster, J.J.³ Dubowy, R.⁴ Bowman, C.P.⁵ Hockenberry-Eaton⁶ Borowitz, M.⁷ Carroll, A.J.⁸ Steuber, C.P.⁹ Pullen, D.J.¹⁰

11
- 0031813927
- Intensive alternating drug pairs for treatment of infant acute lymphoblastic leukemia
- A Pediatric Oncology Group study.
- (1998) J Ped Hematol/Oncol , vol.20 , pp. 229-233
- Lauer, S.J.¹ Camitta, B.M.² Leventhal, B.G.³ Mahoney, D.⁴ Shuster, J.J.⁵ Kiefer, G.⁶ Pullen, J.⁷ Steuber, C.P.⁸ Carroll, A.J.⁹ Kamen, B.¹⁰

12
- 35549013847
- A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A pediatric oncology group phase III randomized trial
- (submitted)
- Lauer, S.J.¹ Shuster, J.J.² Mahoney, D.H.³ Winick, N.⁴ Toledano, S.⁵ Munoz, L.⁶ Kiefer, G.⁷ Pullen, J.⁸ Steuber, C.P.⁹ Camitta, B.M.¹⁰

13
- 0000957062
- Asymptotically efficient rank invariant test procedures
- (1972) J Roy Stat Assoc Ser A , vol.135 , pp. 185-198
- Peto, R.¹ Peto, J.²

14
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

15
- 0017365573
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient
- (1977) Br J Cancer , vol.35 , pp. 1-35
- Peto, R.¹ Pike, M.² Armitage, P.³ Breslow, N.E.⁴ Cox, D.R.⁵ Howard, S.V.⁶ Mantel, N.⁷ McPherson, K.⁸ Peto, J.⁹ Smith, P.G.¹⁰

16
- 0000336139
- Regression models and life-tables
- (1972) J Roy Stat Assoc Ser B , vol.34 , pp. 187-202
- Cox, D.R.¹

17
- 0006583421
- Statistical Analysis of Failure Time Data. Wiley: New York
- (1980) , pp. 163-178
- Kalbfleisch, J.D.¹ Prentice, R.L.²

18
- 0029739087
- Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia
- (1996) J Clin Oncol , vol.14 , pp. 2803-2811
- Winick, N.¹ Shuster, J.J.² Bowman, W.P.³ Borowitz, M.⁴ Farrow, A.⁵ Jacaruso, D.⁶ Buchanan, G.R.⁷ Kamen, B.A.⁸

19
- 0001619269
- Results of the DCLSG study ALL 8 (1991-1997): BFM oriented treatment without cranial irradiation and comparing conventional oral and high dose intravenous 6-mercaptopurine
- (1999) Med Ped Oncol , vol.33 , pp. 169
- Kamps, W.A.¹ Bokkerink, J.P.M.² Hakvoort-Cammel, F.G.A.J.³ Weening, R.S.⁴ Veerman, A.J.P.⁵ v Weerden, J.F.⁶ v Werring, E.R.⁷ vd Does-vd Berg, A.⁸

20
- 0019952884
- Rationale for the use of alternating non-cross-resistant chemotherapy
- (1982) Cancer Treat Rep , vol.66 , pp. 439-449
- Goldie, J.H.¹ Coldman, A.J.² Gudauskas, G.A.³

21
- 0025328804
- Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13)
- A Pediatric Oncology Group study.
- (1990) Blood , vol.76 , pp. 117-122
- Crist, W.M.¹ Carroll, A.J.² Shuster, J.J.³ Behm, F.G.⁴ Whitehead, M.⁵ Vieti, T.J.⁶ Look, A.T.⁷ Mahoney, D.⁸ Ragab, A.⁹ Pullen, D.J.¹⁰ Land, V.J.¹¹

22
- 0025063464
- Cytogenetics of pre-B cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)
- (1990) J Clin Oncol , vol.8 , pp. 1380-1388
- Raimondi, S.C.¹ Behm, F.G.² Roberson, P.K.³ Williams, D.L.⁴ Pui, C.-H.⁵ Crist, W.M.⁶ Look, A.T.⁷ Rivera, G.K.⁸

23
- 0025091057
- Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome
- A Pediatric Oncology Group study.
- (1990) Blood , vol.76 , pp. 489-494
- Crist, W.¹ Carroll, A.² Shuster, J.³ Jackson, J.⁴ Head, D.⁵ Borowitz, M.⁶ Behm, F.⁷ Link, M.⁸ Ragab, A.⁹ Hirt, A.¹⁰ Brock, B.¹¹ Land, V.¹² Pullen, J.¹³

24
- 0034611661
- Outcome of treatment in children with Philadelphia-positive acute lymphoblastic leukemia
- (2000) New Engl J Med , vol.342 , pp. 998-1006
- Arico, M.¹ Valsecchi, M.G.² Camitta, B.³ Schrappe, M.⁴ Chessells, J.⁵ Baruchel, A.⁶ Gaynon, P.⁷ Silverman, L.⁸ Janka-Schaub, G.⁹ Kams, W.¹⁰ Pui, C.H.¹¹ Masera, G.¹²

25
- 0026518781
- Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A pediatric oncology group study
- (1992) J Clin Oncol , vol.10 , pp. 606-613
- Trueworthy, R.¹ Shuster, J.J.² Look, T.³ Crist, W.⁴ Borowitz, M.⁵ Carroll, A.⁶ Frankel, L.⁷ Harris, M.⁸ Wagner, H.⁹ Haggard, M.¹⁰ Mosijczuk, A.¹¹ Pullen, J.¹² Steuber, P.¹³ Land, V.¹⁴

26
- 0021969545
- Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
- (1985) Blood , vol.65 , pp. 1079-1086
- Look, A.T.¹ Roberson, P.K.² Williams, D.L.³ Rivera, G.⁴ Bowman, W.P.⁵ Pui, C.-H.⁶ Ochs, J.⁷ Abromowitch, M.⁸ Kalwinsky, D.⁹ Dahl, G.V.¹⁰ George, S.¹¹ Murphy, S.B.¹²

27
- 0027437146
- DNA aneuploidy in childhood acute lymphoblastic leukemia: Relation to clinical determinants and prognosis within four consecutive BFM trials
- (1994) Rec Res Cancer Res , vol.131 , pp. 113-120
- Hiddemann, W.¹ Harbott, J.² Ludwig, W.-D.³ Ritter, J.⁴ Nehmer, A.⁵ Reitter, A.⁶ Kolkmeyer, A.⁷ Laing, T.⁸ Riehm, H.⁹

28
- 17444441536
- Prognostic impact of trisomies of chromosomes 10, 17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)
- (2000) J Clin Oncol , vol.18 , pp. 1876-1887
- Heerema, N.A.¹ Sather, H.N.² Sensel, M.G.³ Zhang, T.⁴ Hutchingson, R.J.⁵ Nachman, P.S.⁶ Lange, B.J.⁷ Steinberz, P.G.⁸ Bostrom, B.C.⁹ Reaman, G.H.¹⁰ Gaynon, P.S.¹¹ Uckun, F.M.¹²

29
- 0031752848
- Surface antigen phenotype can predict TEL-AML 1 rearrangement in childhood B-precursor ALL: A pediatric oncology group study
- (1998) Leukemia , vol.12 , pp. 1764-1770
- Borowitz, M.J.¹ Rubnitz, J.² Nash, M.³ Pullen, D.J.⁴ Camitta, B.M.⁵

30
- 0033966455
- Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A pediatric oncology group study
- (2000) J Clin Oncol , vol.18 , pp. 813-823
- Pollock, B.H.¹ DeBaun, M.R.² Camitta, B.M.³ Shuster, J.J.⁴ Ravindranath, Y.⁵ Pullen, J.D.⁶ Land, V.J.⁷ Mahoney, D.H.⁸ Lauer, S.J.⁹ Murphy, S.B.¹⁰

31
- 0031879085
- Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: A pediatric oncology group study
- (1998) J Clin Oncol , vol.16 , pp. 2854-2863
- Shuster, J.J.¹ Wacker, P.² Pullen, J.³ Humbert, J.⁴ Land, V.J.⁵ Mahoney, D.H.⁶ Lauer, S.⁷ Look, A.T.⁸ Borowitz, M.J.⁹ Carroll, A.J.¹⁰ Camitta, B.M.¹¹

32
- 0028152851
- Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: Results and conclusions of the multicenter trial ALL-BFM 86
- (1994) Blood , vol.84 , pp. 3122-3133
- Reiter, A.¹ Schrappe, M.² Ludwig, W.-D.³ Hiddermann, W.⁴ Sauter, S.⁵ Henze, G.⁶ Zimmermann, M.⁷ Lampert, F.⁸ Havers, W.⁹ Neithammer, D.¹⁰ Odenwald, E.¹¹ Ritter, J.¹² Mann, G.¹³ Welte, K.¹⁴ Gadner, H.¹⁵ Riehm, H.¹⁶

33
- 4243925237
- A phase I study of 2-amino-9-B-D-arabinosyl-6-methosy-9H-purine (506U78) administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies
- (1999) Blood , vol.94
- Kurtzberg, J.¹ Ernst, T.J.² Keating, M.J.³ Gandhi, V.⁴ Hodge, J.P.⁵ Kisor, D.F.⁶ Therriault, R.⁷ Stephens, C.⁸ Levin, J.⁹ Krenitsky, T.¹⁰ Elion, G.B.¹¹ Mitchell, B.S.¹²

34
- 0032747903
- Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
- (1999) Leukemia , vol.13 , pp. 1696-1707
- Pullen, J.¹ Shuster, J.J.² Link, M.³ Borowitz, M.⁴ Amylon, M.⁵ Carroll, A.J.⁶ Land, V.⁷ Look, A.T.⁸ McIntyre, B.⁹ Camitta, B.¹⁰

35
- 0003216377
- High risk infant ALL - Improved survival with intensive chemotherapy
- (1998) ASCO Proc , vol.17
- Dreyer, Z.E.¹ Steuber, C.P.² Bowman, W.P.³ Murray, J.C.⁴ Coppes, M.J.⁵ Dinndorf, P.⁶ Camitta, B.⁷

36
- 0344542098
- Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-a pediatric oncology group study
- (1998) J Clin Oncol , vol.16 , pp. 1712-1722
- Mahoney, D.H.¹ Shuster, J.J.² Nitschke, R.³ Lauer, S.J.⁴ Steuber, C.P.⁵ Winick, N.⁶ Camitta, B.M.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.